| 发明名称 |
SUPPRESSOR OF THE ENDOGENOUS INTERFERON-GAMMA |
| 摘要 |
The invention relates to suppressors of endogenous human interferon-gamma (INF-γ) applicable in treatment of diseases associated with impaired activity of endogenous IFN-γ. The suppressors of the invention are useful in treating autoimmune diseases and for prevention of graft arteriosclerosis and rejection of organs in allograft transplanted patients. The invention includes inactive analogues or variants of IFN-γ having preserved affinity to the IFN-γ receptor, genetically modified in the domain responsible for triggering the signal transduction pathway. |
| 申请公布号 |
US2014212383(A1) |
申请公布日期 |
2014.07.31 |
| 申请号 |
US201414243861 |
申请日期 |
2014.04.02 |
| 申请人 |
Ivanov Ivan;Nacheva Genoveva;Petrov Stefan;Grigoleit Hans-Guenther |
发明人 |
Ivanov Ivan;Nacheva Genoveva;Petrov Stefan;Grigoleit Hans-Guenther |
| 分类号 |
C07K14/57 |
主分类号 |
C07K14/57 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An IFN-γ modulator composition comprising an IFN-γ suppressor, wherein the IFN-γ suppressor has preserved affinity to an IFN-γ receptor, wherein the IFN-γ suppressor is a variant of SEQ ID NO: 5, and wherein the amino acid sequence of the IFN-γ suppressor comprises at least one modification selected from the group consisting of amino acid substitutions at positions 86, 87, 88, and combinations thereof. |
| 地址 |
Sofia BG |
